1 Longerich T.Hepatocellular carcinoma[J].Pathologe,2020,41(5):478-487. 2 Rimassa L,Pressiani T,Merle P.Systemic treatment options in hepatocellular carcinoma[J].Liver Cancer,2019,8(6):427-446. 3 Couri T,Pillai A.Goals and targets for personalized therapy for HCC[J].Hepatol Int,2019,13(2):125-137. 4 Hajjari M,Salavaty A.HOTAIR:an oncogenic long non-coding RNA in different cancers[J].Cancer Biol Med,2015,12(1):1-9. 5 Liu J,Peng WX,Mo YY,et al.MALAT1-mediated tumorigenesis[J].Front Biosci (Landmark Ed),2017,22(1):66-80. 6 Asghar U,Witkiewicz AK,Turner NC,et al.The history and future of targeting cyclin-dependent kinases in cancer therapy[J].Nat Rev Drug Discov,2015,14(2):130-146. 7 Su C,Wang W,Mo J,et al.Long noncoding RNA HOXC-AS3 interacts with CDK2 to promote proliferation in hepatocellular carcinoma[J].Biomark Res,2022,10(1):65. 8 Chandra Gupta S,Nandan Tripathi Y.Potential of long non-coding RNAs in cancer patients:From biomarkers to therapeutic targets[J].Int J Cancer,2017,140(9):1955-1967. 9 Zhang DY,Sun QC,Zou XJ,et al.Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2[J].J Exp Clin Cancer Res,2020,39(1):229. 10 Gao R,Fang C,Xu J,et al.LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145[J].Arch Biochem Biophys,2019,663:183-191. 11 He T,Zhang L,Kong Y,et al.Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis[J].Int J Oncol,2017,51(6):1722-1730. 12 Li Y,Zhou B,Dai J,et al.Aberrant upregulation of LRRC1 contributes to human hepatocellular carcinoma[J].Mol Biol Rep,2013,40(7):4543-4551. 13 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108. 14 Sheng L,Wei R.Long non-coding RNA-CASC15 promotes cell proliferation,migration,and invasion by activating Wnt/beta-catenin signaling pathway in Melanoma[J].Pathobiology,2020,87(1):20-29. 15 Zhang C,Wang GX,Fu B,et al.LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p[J].Eur Rev Med Pharmacol Sci,2019,23(19):8303-8309. 16 Yu L,Xu Q,Yu W,et al.LncRNA cancer susceptibility candidate 15 accelerates the breast cancer cells progression via miR-153-3p/KLF5 positive feedback loop[J].Biochem Biophys Res Commun,2018,506(4):819-825. 17 Huarte M.The emerging role of lncRNAs in cancer[J].Nat Med,2015,21(11):1253-1261. 18 Sun Y,Liu Z,Huang L,et al.MiR-144-3p inhibits the proliferation,migration and invasion of lung adenocargen cancer cells by targeting COL11A1[J].J Chemother,2021,33(6):409-419. 19 Wang P,Yang Z,Ye T,et al.lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET[J].J Exp Clin Cancer Res,2020,39(1):7. 20 Xing B,Shen C,Yang Q,et al.miR-144-3p represses hepatocellular carcinoma progression by affecting cell aerobic glycolysis via FOXK1[J].Int J Exp Pathol,2023,104(3):117-127. 21 Martin JW,Yoshimoto M,Ludkovski O,et al.Analysis of segmental duplications,mouse genome synteny and recurrent cancer-associated amplicons in human chromosome 6p21-p12[J].Cytogenet Genome Res,2010,128(4):199-213. 22 Chochi Y,Kawauchi S,Nakao M,et al.A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma:an array-based comparative genomic hybridization study[J].J Pathol,2009,217(5):677-684. 23 Jia D,Wei L,Guo W,et al.Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma[J].Hepatology,2011,54(4):1227-1236. 24 Li Y,Chen G,Yan Y,et al.CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging[J].Eur J Pharmacol,2019,860:172589. 25 Gai SY,Yuan ZH.Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells[J].Neoplasma,2020,67(2):333-343. |